MOUNTAIN LAKES, N.J., March 24, 2026 /PRNewswire/ — LiviWell, a women’s health company dedicated to developing innovative solutions for intimate health, today announced that the U.S. Food and Drug Administration (FDA) has cleared Livi, a first-of-its-kind device designed to support vaginal health by absorbing semen and other post-intercourse fluids.
The findings help explain why some people appear far more likely than others to transmit respiratory viruses and offer new insight into how influenza spreads through the air.
Researchers at Ouachita Baptist University are creating stitches loaded with anti-inflammatory drugs to deliver the medication directly to the injury.
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Photonova Spectra solution.
By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students.
Built for high reliability, world’s only lumenless defibrillation lead approved for placement in the left bundle branch area
This breakthrough could lead to next-generation medical tools that track disease, guide treatment and monitor the body in real time
The method relies on the fact that deuterium, once in the body, participates in biochemical reactions alongside ordinary hydrogen and becomes incorporated into the carbon-hydrogen bonds of organic compounds.
Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy.
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients.